<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT932-16787</title>
	</head>
	<body>
		<main>
			<p>930403 FT  03 APR 93 / Finance &amp; The Family: Pharmaceutical shares catch a nasty cold - At a Glance Pharmaceutical stocks, for a long time the glamour boys of the stock market, have taken a beating in recent months. The plans of President Bill Clinton and his wife to reform the US healthcare sector started the rot, but the UK giants have had suffered setbacks of their own. Glaxo saw the departure of its chief executive; and this week Wellcome shares suffered from a report questioning the efficacy of its anti-AIDS drug, AZT. These stocks were trading on such high price-earnings ratios that bad news was bound to have a disproportionate effect on their prices.</p>
		</main>
</body></html>
            